Variation in the glucose transporter gene SLC2A2 is associated with glycaemic response to metformin

Metformin is the first-line antidiabetic drug with over 100 million users worldwide, yet its mechanism of action remains unclear1. Here the Metformin Genetics (MetGen) Consortium reports a three-stage genome-wide association study (GWAS), consisting of 13,123 participants of different ancestries. Th...

Full description

Bibliographic Details
Main Authors: Kaixin, Z, Yee, S, Seiser, E, van Leeuwen, N, Tavendale, R, Bennett, A, Groves, C, Coleman, R, van der Heijden, A, Beulens, J, de Keyser, C, Zaharenko, L, Rotroff, D, Out, M, Jablonski, K, Chen, L, Javorský, M, Židzik, J, Levin, A, William, L, Dujic, T, Semiz, S, Kubo, M, Chien, H, Maeda, S, Witte, J, Wu, L, Tkáč, I, Kooy, A, van Schaik, R, Stehouwer, C, Logie, L, MetGen Investigators, DPP Investigators, ACCORD Investigators, Sutherland, C, Klovins, J, Pirags, V, Hofman, A, Stricker, B, Motsinger-Reif, A, Wagner, M, Innocenti, F, 't Hart, L, Holman, R, McCarthy, M, Hedderson, M, Palmer, C, Florez, J, Giacomini, K, Pearson, E
Format: Journal article
Published: Nature Publishing Group 2016
_version_ 1826273276123414528
author Kaixin, Z
Yee, S
Seiser, E
van Leeuwen, N
Tavendale, R
Bennett, A
Groves, C
Coleman, R
van der Heijden, A
Beulens, J
de Keyser, C
Zaharenko, L
Rotroff, D
Out, M
Jablonski, K
Chen, L
Javorský, M
Židzik, J
Levin, A
William, L
Dujic, T
Semiz, S
Kubo, M
Chien, H
Maeda, S
Witte, J
Wu, L
Tkáč, I
Kooy, A
van Schaik, R
Stehouwer, C
Logie, L
MetGen Investigators
DPP Investigators
ACCORD Investigators
Sutherland, C
Klovins, J
Pirags, V
Hofman, A
Stricker, B
Motsinger-Reif, A
Wagner, M
Innocenti, F
't Hart, L
Holman, R
McCarthy, M
Hedderson, M
Palmer, C
Florez, J
Giacomini, K
Pearson, E
author_facet Kaixin, Z
Yee, S
Seiser, E
van Leeuwen, N
Tavendale, R
Bennett, A
Groves, C
Coleman, R
van der Heijden, A
Beulens, J
de Keyser, C
Zaharenko, L
Rotroff, D
Out, M
Jablonski, K
Chen, L
Javorský, M
Židzik, J
Levin, A
William, L
Dujic, T
Semiz, S
Kubo, M
Chien, H
Maeda, S
Witte, J
Wu, L
Tkáč, I
Kooy, A
van Schaik, R
Stehouwer, C
Logie, L
MetGen Investigators
DPP Investigators
ACCORD Investigators
Sutherland, C
Klovins, J
Pirags, V
Hofman, A
Stricker, B
Motsinger-Reif, A
Wagner, M
Innocenti, F
't Hart, L
Holman, R
McCarthy, M
Hedderson, M
Palmer, C
Florez, J
Giacomini, K
Pearson, E
author_sort Kaixin, Z
collection OXFORD
description Metformin is the first-line antidiabetic drug with over 100 million users worldwide, yet its mechanism of action remains unclear1. Here the Metformin Genetics (MetGen) Consortium reports a three-stage genome-wide association study (GWAS), consisting of 13,123 participants of different ancestries. The C allele of rs8192675 in the intron of SLC2A2, which encodes the facilitated glucose transporter GLUT2, was associated with a 0.17% (P = 6.6 × 10−14) greater metformin-induced reduction in hemoglobin A1c (HbA1c) in 10,577 participants of European ancestry. rs8192675 was the top cis expression quantitative trait locus (cis-eQTL) for SLC2A2 in 1,226 human liver samples, suggesting a key role for hepatic GLUT2 in regulation of metformin action. Among obese individuals, C-allele homozygotes at rs8192675 had a 0.33% (3.6 mmol/mol) greater absolute HbA1c reduction than T-allele homozygotes. This was about half the effect seen with the addition of a DPP-4 inhibitor, and equated to a dose difference of 550 mg of metformin, suggesting rs8192675 as a potential biomarker for stratified medicine.
first_indexed 2024-03-06T22:25:44Z
format Journal article
id oxford-uuid:569d2974-7b69-473a-b4e9-3295ffdf4d9b
institution University of Oxford
last_indexed 2024-03-06T22:25:44Z
publishDate 2016
publisher Nature Publishing Group
record_format dspace
spelling oxford-uuid:569d2974-7b69-473a-b4e9-3295ffdf4d9b2022-03-26T16:51:24ZVariation in the glucose transporter gene SLC2A2 is associated with glycaemic response to metforminJournal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:569d2974-7b69-473a-b4e9-3295ffdf4d9bSymplectic Elements at OxfordNature Publishing Group2016Kaixin, ZYee, SSeiser, Evan Leeuwen, NTavendale, RBennett, AGroves, CColeman, Rvan der Heijden, ABeulens, Jde Keyser, CZaharenko, LRotroff, DOut, MJablonski, KChen, LJavorský, MŽidzik, JLevin, AWilliam, LDujic, TSemiz, SKubo, MChien, HMaeda, SWitte, JWu, LTkáč, IKooy, Avan Schaik, RStehouwer, CLogie, LMetGen InvestigatorsDPP InvestigatorsACCORD InvestigatorsSutherland, CKlovins, JPirags, VHofman, AStricker, BMotsinger-Reif, AWagner, MInnocenti, F't Hart, LHolman, RMcCarthy, MHedderson, MPalmer, CFlorez, JGiacomini, KPearson, EMetformin is the first-line antidiabetic drug with over 100 million users worldwide, yet its mechanism of action remains unclear1. Here the Metformin Genetics (MetGen) Consortium reports a three-stage genome-wide association study (GWAS), consisting of 13,123 participants of different ancestries. The C allele of rs8192675 in the intron of SLC2A2, which encodes the facilitated glucose transporter GLUT2, was associated with a 0.17% (P = 6.6 × 10−14) greater metformin-induced reduction in hemoglobin A1c (HbA1c) in 10,577 participants of European ancestry. rs8192675 was the top cis expression quantitative trait locus (cis-eQTL) for SLC2A2 in 1,226 human liver samples, suggesting a key role for hepatic GLUT2 in regulation of metformin action. Among obese individuals, C-allele homozygotes at rs8192675 had a 0.33% (3.6 mmol/mol) greater absolute HbA1c reduction than T-allele homozygotes. This was about half the effect seen with the addition of a DPP-4 inhibitor, and equated to a dose difference of 550 mg of metformin, suggesting rs8192675 as a potential biomarker for stratified medicine.
spellingShingle Kaixin, Z
Yee, S
Seiser, E
van Leeuwen, N
Tavendale, R
Bennett, A
Groves, C
Coleman, R
van der Heijden, A
Beulens, J
de Keyser, C
Zaharenko, L
Rotroff, D
Out, M
Jablonski, K
Chen, L
Javorský, M
Židzik, J
Levin, A
William, L
Dujic, T
Semiz, S
Kubo, M
Chien, H
Maeda, S
Witte, J
Wu, L
Tkáč, I
Kooy, A
van Schaik, R
Stehouwer, C
Logie, L
MetGen Investigators
DPP Investigators
ACCORD Investigators
Sutherland, C
Klovins, J
Pirags, V
Hofman, A
Stricker, B
Motsinger-Reif, A
Wagner, M
Innocenti, F
't Hart, L
Holman, R
McCarthy, M
Hedderson, M
Palmer, C
Florez, J
Giacomini, K
Pearson, E
Variation in the glucose transporter gene SLC2A2 is associated with glycaemic response to metformin
title Variation in the glucose transporter gene SLC2A2 is associated with glycaemic response to metformin
title_full Variation in the glucose transporter gene SLC2A2 is associated with glycaemic response to metformin
title_fullStr Variation in the glucose transporter gene SLC2A2 is associated with glycaemic response to metformin
title_full_unstemmed Variation in the glucose transporter gene SLC2A2 is associated with glycaemic response to metformin
title_short Variation in the glucose transporter gene SLC2A2 is associated with glycaemic response to metformin
title_sort variation in the glucose transporter gene slc2a2 is associated with glycaemic response to metformin
work_keys_str_mv AT kaixinz variationintheglucosetransportergeneslc2a2isassociatedwithglycaemicresponsetometformin
AT yees variationintheglucosetransportergeneslc2a2isassociatedwithglycaemicresponsetometformin
AT seisere variationintheglucosetransportergeneslc2a2isassociatedwithglycaemicresponsetometformin
AT vanleeuwenn variationintheglucosetransportergeneslc2a2isassociatedwithglycaemicresponsetometformin
AT tavendaler variationintheglucosetransportergeneslc2a2isassociatedwithglycaemicresponsetometformin
AT bennetta variationintheglucosetransportergeneslc2a2isassociatedwithglycaemicresponsetometformin
AT grovesc variationintheglucosetransportergeneslc2a2isassociatedwithglycaemicresponsetometformin
AT colemanr variationintheglucosetransportergeneslc2a2isassociatedwithglycaemicresponsetometformin
AT vanderheijdena variationintheglucosetransportergeneslc2a2isassociatedwithglycaemicresponsetometformin
AT beulensj variationintheglucosetransportergeneslc2a2isassociatedwithglycaemicresponsetometformin
AT dekeyserc variationintheglucosetransportergeneslc2a2isassociatedwithglycaemicresponsetometformin
AT zaharenkol variationintheglucosetransportergeneslc2a2isassociatedwithglycaemicresponsetometformin
AT rotroffd variationintheglucosetransportergeneslc2a2isassociatedwithglycaemicresponsetometformin
AT outm variationintheglucosetransportergeneslc2a2isassociatedwithglycaemicresponsetometformin
AT jablonskik variationintheglucosetransportergeneslc2a2isassociatedwithglycaemicresponsetometformin
AT chenl variationintheglucosetransportergeneslc2a2isassociatedwithglycaemicresponsetometformin
AT javorskym variationintheglucosetransportergeneslc2a2isassociatedwithglycaemicresponsetometformin
AT zidzikj variationintheglucosetransportergeneslc2a2isassociatedwithglycaemicresponsetometformin
AT levina variationintheglucosetransportergeneslc2a2isassociatedwithglycaemicresponsetometformin
AT williaml variationintheglucosetransportergeneslc2a2isassociatedwithglycaemicresponsetometformin
AT dujict variationintheglucosetransportergeneslc2a2isassociatedwithglycaemicresponsetometformin
AT semizs variationintheglucosetransportergeneslc2a2isassociatedwithglycaemicresponsetometformin
AT kubom variationintheglucosetransportergeneslc2a2isassociatedwithglycaemicresponsetometformin
AT chienh variationintheglucosetransportergeneslc2a2isassociatedwithglycaemicresponsetometformin
AT maedas variationintheglucosetransportergeneslc2a2isassociatedwithglycaemicresponsetometformin
AT wittej variationintheglucosetransportergeneslc2a2isassociatedwithglycaemicresponsetometformin
AT wul variationintheglucosetransportergeneslc2a2isassociatedwithglycaemicresponsetometformin
AT tkaci variationintheglucosetransportergeneslc2a2isassociatedwithglycaemicresponsetometformin
AT kooya variationintheglucosetransportergeneslc2a2isassociatedwithglycaemicresponsetometformin
AT vanschaikr variationintheglucosetransportergeneslc2a2isassociatedwithglycaemicresponsetometformin
AT stehouwerc variationintheglucosetransportergeneslc2a2isassociatedwithglycaemicresponsetometformin
AT logiel variationintheglucosetransportergeneslc2a2isassociatedwithglycaemicresponsetometformin
AT metgeninvestigators variationintheglucosetransportergeneslc2a2isassociatedwithglycaemicresponsetometformin
AT dppinvestigators variationintheglucosetransportergeneslc2a2isassociatedwithglycaemicresponsetometformin
AT accordinvestigators variationintheglucosetransportergeneslc2a2isassociatedwithglycaemicresponsetometformin
AT sutherlandc variationintheglucosetransportergeneslc2a2isassociatedwithglycaemicresponsetometformin
AT klovinsj variationintheglucosetransportergeneslc2a2isassociatedwithglycaemicresponsetometformin
AT piragsv variationintheglucosetransportergeneslc2a2isassociatedwithglycaemicresponsetometformin
AT hofmana variationintheglucosetransportergeneslc2a2isassociatedwithglycaemicresponsetometformin
AT strickerb variationintheglucosetransportergeneslc2a2isassociatedwithglycaemicresponsetometformin
AT motsingerreifa variationintheglucosetransportergeneslc2a2isassociatedwithglycaemicresponsetometformin
AT wagnerm variationintheglucosetransportergeneslc2a2isassociatedwithglycaemicresponsetometformin
AT innocentif variationintheglucosetransportergeneslc2a2isassociatedwithglycaemicresponsetometformin
AT thartl variationintheglucosetransportergeneslc2a2isassociatedwithglycaemicresponsetometformin
AT holmanr variationintheglucosetransportergeneslc2a2isassociatedwithglycaemicresponsetometformin
AT mccarthym variationintheglucosetransportergeneslc2a2isassociatedwithglycaemicresponsetometformin
AT heddersonm variationintheglucosetransportergeneslc2a2isassociatedwithglycaemicresponsetometformin
AT palmerc variationintheglucosetransportergeneslc2a2isassociatedwithglycaemicresponsetometformin
AT florezj variationintheglucosetransportergeneslc2a2isassociatedwithglycaemicresponsetometformin
AT giacominik variationintheglucosetransportergeneslc2a2isassociatedwithglycaemicresponsetometformin
AT pearsone variationintheglucosetransportergeneslc2a2isassociatedwithglycaemicresponsetometformin